$124.39
4.14% day before yesterday
Nasdaq, Sep 06, 10:10 pm CET
ISIN
US4523271090
Symbol
ILMN
Sector
Industry

Illumina Stock price

$124.39
+8.03 6.90% 1M
-7.27 5.52% 6M
-11.27 8.31% YTD
-31.49 20.20% 1Y
-330.59 72.66% 3Y
-138.67 52.71% 5Y
-51.17 29.15% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-5.37 4.14%
ISIN
US4523271090
Symbol
ILMN
Sector
Industry

Key metrics

Market capitalization $19.82b
Enterprise Value $21.74b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 61.07
EV/Sales (TTM) EV/Sales 4.91
P/S ratio (TTM) P/S ratio 4.47
P/B ratio (TTM) P/B ratio 13.77
Revenue growth (TTM) Revenue growth -0.72%
Revenue (TTM) Revenue $4.43b
EBIT (operating result TTM) EBIT $492.00m
Free Cash Flow (TTM) Free Cash Flow $356.00m
Cash position $994.00m
EPS (TTM) EPS $-19.17
P/E forward negative
P/S forward 4.54
EV/Sales forward 4.98
Short interest 2.99%
Show more

Create a Free Account to create an Illumina alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Illumina Stock Analysis

Analyst Opinions

27 Analysts have issued a Illumina forecast:

14x Buy
52%
12x Hold
44%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a Illumina forecast:

Buy
52%
Hold
44%
Sell
4%

Financial data from Illumina

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
4,429 4,429
1% 1%
100%
- Direct Costs 1,682 1,682
0% 0%
38%
2,747 2,747
1% 1%
62%
- Selling and Administrative Expenses 520 520
42% 42%
12%
- Research and Development Expense 1,307 1,307
4% 4%
30%
920 920
80% 80%
21%
- Depreciation and Amortization 428 428
1% 1%
10%
EBIT (Operating Income) EBIT 492 492
466% 466%
11%
Net Profit -3,044 -3,044
27% 27%
-69%

In millions USD.

Don't miss a Thing! We will send you all news about Illumina directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Illumina Stock News

Neutral
PRNewsWire
5 days ago
SAN DIEGO , Sept. 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, welcomes the European Court of Justice's (ECJ's) judgment today ruling that the European Commission did not have jurisdiction over Illumina's acquisition of GRAIL.
Positive
Reuters
5 days ago
Europe's top court on Tuesday backed U.S. gene sequencing company Illumina's fight against EU antitrust regulators' investigation into its $7.1 billion bid for cancer diagnostic test maker Grail.
Neutral
PRNewsWire
9 days ago
Data Support Clinical Performance of Galleri   to Detect More Aggressive Prostate Cancers MENLO PARK, Calif. , Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings of the performance of its Galleri® multi-cancer early detection (MCED) test in prostate cancer were publish...
More Illumina News

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Head office United States
CEO Jacob Thaysen
Employees 12,010
Founded 1998
Website www.illumina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today